Moderna announces clinical and program updates at 4th vaccines day
Next-generation, refrigerator-stable covid-19 vaccine candidate, mrna-1283, has dosed first participant in its phase 3 trial company expects to file for approval of its investigational rsv vaccine candidate, mrna-1345, this quarter company's first influenza candidate, mrna-1010, did not accrue sufficient cases at the interim efficacy analysis to declare early success in the phase 3 northern hemisphere efficacy trial and the independent dsmb recommended continuation of efficacy follow-up preliminary immunogenicity analysis from the northern hemisphere trial showed mrna-1010 demonstrated titers consistent with superiority against influenza a strains (h1n1, h3n2) and non-inferiority against influenza b strains (b/victoria, b/yamagata) versus the licensed comparator moderna announces new development candidates against lyme disease, the company's first bacterial vaccine, and norovirus, an enteric virus company establishes 2027 financial framework for the respiratory franchise cambridge, ma / accesswire / april 11, 2023 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced clinical and program updates demonstrating expansion and advancement of its mrna pipeline. the updates include advancements in the company's respiratory and latent virus portfolios, new vaccine candidates, and commercial and financial framework announcements for the respiratory vaccines business.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission